55 related articles for article (PubMed ID: 33879870)
1. Understanding the Variability of 22q11.2 Deletion Syndrome: The Role of Epigenetic Factors.
Cillo F; Coppola E; Habetswallner F; Cecere F; Pignata L; Toriello E; De Rosa A; Grilli L; Ammendola A; Salerno P; Romano R; Cirillo E; Merla G; Riccio A; Pignata C; Giardino G
Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540380
[TBL] [Abstract][Full Text] [Related]
2. Platelet findings in 22q11.2 deletion syndrome correlate with disease manifestations but do not correlate with GPIb surface expression.
Campbell IM; Crowley TB; Jobaliya C; Bailey A; McGinn DE; Gaiser K; Bassett A; Gur RE; Morrow B; Emanuel BS; Franco AT; French D; Zackai EH; McDonald-McGinn DM; Lambert MP
Clin Genet; 2023 Jan; 103(1):109-113. PubMed ID: 36075864
[TBL] [Abstract][Full Text] [Related]
3. Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review.
de Boer J; Boot E; van Gils L; van Amelsvoort T; Zinkstok J
Am J Med Genet A; 2019 Nov; 179(11):2292-2306. PubMed ID: 31407842
[TBL] [Abstract][Full Text] [Related]
4. Targeted massively parallel sequencing of candidate regions on chromosome 22q predisposing to multiple schwannomas: An analysis of 51 individuals in a single-center experience.
Piotrowski A; Koczkowska M; Poplawski AB; Bartoszewski R; Króliczewski J; Mieczkowska A; Gomes A; Crowley MR; Crossman DK; Chen Y; Lao P; Serra E; Llach MC; Castellanos E; Messiaen LM
Hum Mutat; 2022 Jan; 43(1):74-84. PubMed ID: 34747535
[TBL] [Abstract][Full Text] [Related]
5. Chromatin regulators in the TBX1 network confer risk for conotruncal heart defects in 22q11.2DS.
Zhao Y; Wang Y; Shi L; McDonald-McGinn DM; Crowley TB; McGinn DE; Tran OT; Miller D; Lin JR; Zackai E; Johnston HR; Chow EWC; Vorstman JAS; Vingerhoets C; van Amelsvoort T; Gothelf D; Swillen A; Breckpot J; Vermeesch JR; Eliez S; Schneider M; van den Bree MBM; Owen MJ; Kates WR; Repetto GM; Shashi V; Schoch K; Bearden CE; Digilio MC; Unolt M; Putotto C; Marino B; Pontillo M; Armando M; Vicari S; Angkustsiri K; Campbell L; Busa T; Heine-Suñer D; Murphy KC; Murphy D; García-Miñaúr S; Fernández L; ; Zhang ZD; Goldmuntz E; Gur RE; Emanuel BS; Zheng D; Marshall CR; Bassett AS; Wang T; Morrow BE
NPJ Genom Med; 2023 Jul; 8(1):17. PubMed ID: 37463940
[TBL] [Abstract][Full Text] [Related]
6. Salivary α-Synuclein as a Candidate Biomarker of Parkinsonism in 22q11.2 Deletion Syndrome.
Fanella M; Cerulli Irelli E; Accinni T; Di Fabio F; Putotto C; Pulvirenti F; Bellomi FE; Di Bonaventura C; Vivacqua G
Mov Disord Clin Pract; 2024 Apr; ():. PubMed ID: 38661486
[TBL] [Abstract][Full Text] [Related]
7. The inflammatory microenvironment in vestibular schwannoma.
Hannan CJ; Lewis D; O'Leary C; Donofrio CA; Evans DG; Roncaroli F; Brough D; King AT; Coope D; Pathmanaban ON
Neurooncol Adv; 2020; 2(1):vdaa023. PubMed ID: 32642684
[TBL] [Abstract][Full Text] [Related]
8. Evans syndrome in the background of 22q11.2 deletion syndrome.
Alawajneh MM; Sameer W; Al Zobi M; Zaheer EA; Talati R; Lesmana H
Pediatr Blood Cancer; 2024 May; ():e31049. PubMed ID: 38711190
[No Abstract] [Full Text] [Related]
9. Value of Exome Sequencing in Diagnosis and Management of Recurrent Non-immune Hydrops Fetalis: A Retrospective Analysis.
Zhou X; Zhou J; Wei X; Yao R; Yang Y; Deng L; Zou G; Wang X; Yang Y; Duan T; Wang J; Sun L
Front Genet; 2021; 12():616392. PubMed ID: 33897756
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic noncoding variants in the neurofibromatosis and schwannomatosis predisposition genes.
Perez-Becerril C; Evans DG; Smith MJ
Hum Mutat; 2021 Oct; 42(10):1187-1207. PubMed ID: 34273915
[TBL] [Abstract][Full Text] [Related]
11. DGCR8 and the six hit, three-step model of schwannomatosis.
Nogué C; Chong AS; Grau E; Han H; Dorca E; Roca C; Mosquera JL; Lázaro C; Foulkes WD; Brunet J; Rivera B
Acta Neuropathol; 2022 Jan; 143(1):115-117. PubMed ID: 34821987
[No Abstract] [Full Text] [Related]
12. Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis.
Smith MJ; Isidor B; Beetz C; Williams SG; Bhaskar SS; Richer W; O'Sullivan J; Anderson B; Daly SB; Urquhart JE; Fryer A; Rustad CF; Mills SJ; Samii A; du Plessis D; Halliday D; Barbarot S; Bourdeaut F; Newman WG; Evans DG
Neurology; 2015 Jan; 84(2):141-7. PubMed ID: 25480913
[TBL] [Abstract][Full Text] [Related]
13. Sporadic vestibular schwannoma: a molecular testing summary.
Sadler KV; Bowers NL; Hartley C; Smith PT; Tobi S; Wallace AJ; King A; Lloyd SKW; Rutherford S; Pathmanaban ON; Hammerbeck-Ward C; Freeman S; Stapleton E; Taylor A; Shaw A; Halliday D; Smith MJ; Evans DG
J Med Genet; 2021 Apr; 58(4):227-233. PubMed ID: 32576656
[TBL] [Abstract][Full Text] [Related]
14. The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.
Kehrer-Sawatzki H; Farschtschi S; Mautner VF; Cooper DN
Hum Genet; 2017 Feb; 136(2):129-148. PubMed ID: 27921248
[TBL] [Abstract][Full Text] [Related]
15. [22q11.2DS Syndrome as a Genetic Subtype of Schizophrenia].
Huertas-Rodríguez CK; Payán-Gómez C; Forero-Castro RM
Rev Colomb Psiquiatr; 2015; 44(1):50-60. PubMed ID: 26578219
[TBL] [Abstract][Full Text] [Related]
16. Typical 22q11.2 deletion syndrome appears to confer a reduced risk of schwannoma.
Evans DG; Messiaen LM; Foulkes WD; Irving REA; Murray AJ; Perez-Becerril C; Rivera B; McDonald-McGinn DM; Stevenson DA; Smith MJ
Genet Med; 2021 Sep; 23(9):1779-1782. PubMed ID: 33879870
[TBL] [Abstract][Full Text] [Related]
17. Unilateral vestibular schwannoma in a patient with schwannomatosis in the absence of LZTR1 mutation.
Mehta GU; Feldman MJ; Wang H; Ding D; Chittiboina P
J Neurosurg; 2016 Dec; 125(6):1469-1471. PubMed ID: 26848914
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
